# IPG Photonics Corp: Form 10-Q for the period ended Sep 30, 2018

- Company: [IPG Photonics Corp](/companies/ipgp.md) (CIK 1111928)
- Form: 10-Q
- Filed: 2018-11-05
- Accepted by EDGAR: Nov 5, 2018, 16:31 ET
- Period: 2018-09-30
- Accession: 0001111928-18-000137
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1111928/000111192818000137/ipgp-20180930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1111928/000111192818000137/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-30 | $356.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-01-01 to 2018-09-30 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-07-01 to 2018-09-30 | $161.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2018-01-01 to 2018-09-30 | $496.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2018-07-01 to 2018-09-30 | $195.2m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-01-01 to 2018-09-30 | $633.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-07-01 to 2018-09-30 | $30.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2018-01-01 to 2018-09-30 | $91.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2018-07-01 to 2018-09-30 | $123.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-30 | $427.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-07-01 to 2018-09-30 | $27.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-30 | $104.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-07-01 to 2018-09-30 | $100.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-01-01 to 2018-09-30 | $328.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-07-01 to 2018-09-30 | $1.84 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-01-01 to 2018-09-30 | $5.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-30 | $1.88 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-30 | $6.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-07-01 to 2018-09-30 | 54,696,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-01-01 to 2018-09-30 | 54,995,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-30 | $280.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-30 | $133.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2018-01-01 to 2018-09-30 | $111.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-09-30 | $647.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-30 | $1.88bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-30 | $2.56bn | us-gaap:Assets |
| Current liabilities | at 2018-09-30 | $218.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-09-30 | $355.3m | us-gaap:Liabilities |
| Long-term debt | at 2018-09-30 | $42.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-09-30 | $3.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-09-30 | $2.21bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 43,361 characters.

*You should read the following discussion in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward looking statements that are based on management's current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements. See "Cautionary Statement Regarding Forward-Looking Statements."*

### Overview

We develop and manufacture a broad line of high-performance fiber lasers, fiber amplifiers and diode lasers that are used in numerous applications, primarily in materials processing. In addition, we offer laser-based systems for certain markets and applications. We sell our products globally to original equipment manufacturers ("OEMs"), system integrators and end users. We market our products internationally primarily through our direct sales force.

We are vertically integrated such that we design and manufacture most of the key components used in our finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers and amplifiers. We also manufacture certain complementary products used with our lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads and chillers.

### Factors and Trends That Affect Our Operations and Financial Results

In reading our financial statements, you should be aware of the following factors and trends that our management believes are important in understanding our financial performance.

*Net sales.* We derive net sales primarily from the sale of fiber lasers and amplifiers. We also sell diode lasers, communications systems, laser systems and complementary products. We sell our products through our direct sales organization and our network of distributors and sales representatives, as well as system integrators. We sell our products to OEMs that supply materials processing laser systems, communications systems, medical laser systems and other laser systems for advanced applications to end users. We also sell our products to end users that build their own systems, which incorporate our products or use our products as an energy or light source. Our scientists and engineers work closely with OEMs, systems integrators and end users to analyze their system requirements and match appropriate fiber laser or amplifier specifications. Our sales cycle varies substantially, ranging from a period of a few weeks to as long as one year or more, but is typically several months.

We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. The majority of our revenue is recognized at a point in time following the transfer of control of products or services to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts.

We develop our products to standard specifications and use a common set of components within our product architectures. Our major products are based upon a common technology platform. We continually enhance these and other products by improving their components and developing new components and new product designs.

The average selling prices of our products generally decrease as the products mature. These decreases result from factors such as decreased manufacturing costs and increases in unit volumes, increased competition, the introduction of new products and market share considerations. In the past, we have lowered our selling prices in order to penetrate new markets and applications. Furthermore, we negotiate discounted selling prices from time to time with certain customers that place high unit volume orders.

*Gross margin*. Our total gross margin can be significantly affected by total net sales in any period, by product mix, that is, the percentage of our revenue in the period that is attributable to higher or lower power products and the mix of sales between laser and amplifier sources and complete systems, by sales mix between OEM customers who purchase devices from us in high unit volumes and other customers, by mix of sales in different geographies and by other factors, some of which are not under our control.

Within each of our product categories, lasers with a higher average power generally have a higher gross margin; higher power lasers use a greater number of optical components, improving absorption of fixed overhead costs and enabling economies of scale in manufacturing. In addition, certain specialty products have a gross margin which is above our corporate average while the profit margins on some systems can be lower than margins for our laser and amplifier sources, depending on the configuration, volume and competitive forces, among other factors.

The mix of sales between OEM customers and other customers can affect gross margin because we provide sales price discounts on products based on the number of units ordered. As the number of OEM customers increase and the number of units ordered increases, the average sales price per unit will be reduced. We expect that the impact of reduced sales price per unit will be offset by the manufacturing efficiency provided by high unit volume orders, but the timing and extent of achieving these efficiencies may not always match the mix of sales in any given time period or be realized at all.

Fluctuations in foreign exchange rates can affect gross margin. Generally, when the U.S. Dollar weakens as compared to the Euro, Chinese Yuan or other foreign currencies in which our product is sold, it will benefit gross margin. When the U.S. dollar strengthens as compared to foreign currencies in which our product is sold, it will be a detriment to gross margin.

We also regularly review our inventory for items that are slow-moving, have been rendered obsolete or determined to be excess. Any provision for such slow-moving, obsolete or excess inventory affects our gross margins. For example, we recorded provisions for slow-moving, obsolete or excess inventory totaling $3.1 million and $4.0 million for the three months ended September 30, 2018 and 2017, respectively, and $16.9 million, $22.8 million and $15.4 million for the years ended December 31, 2017, 2016 and 2015, respectively.

*Sales and marketing expense.* We expect to continue to expand our worldwide direct sales organization, build and expand applications centers, hire additional sales and marketing personnel at our existing and new geographic locations as well as to support sales of new product lines, increase the number of units for demonstration purposes and otherwise increase expenditures on sales and marketing activities in order to support the growth in our net sales. As such, we expect that our sales and marketing expenses will increase in the aggregate.

*Research and development expense.* We plan to continue to invest in research and development to improve our existing components and products and develop new components, products, systems and applications technology. The amount of research and development expense we incur may vary from period to period. In general, if net sales continue to increase we expect research and development expense to increase in the aggregate.

*General and administrative expense.* We expect our general and administrative expenses to increase as we continue to invest in systems and resources in management, finance, legal, information technology, human resources and administration to support our worldwide operations. Legal expenses vary from quarter to quarter based primarily upon the level of litigation and transaction activities.

*Foreign Exchange.* Because we are a U.S. based company doing business globally, we have both translational and transactional exposure to fluctuations in foreign currency exchange rates. Changes in the relative exchange rate between the U.S. dollar and the foreign currencies in which our subsidiaries operate directly affects our sales, costs and earnings. Differences in the relative exchange rates between where we sell our products and where we incur manufacturing and other operating costs (primarily in the U.S., Germany and Russia) also affects our costs and earnings. Certain currencies experiencing significant exchange rate fluctuations like the Euro, the Russian Ruble, the Japanese Yen and Chinese Yuan have had and could have an additional significant impact on our sales, costs and earnings. Our ability to adjust the foreign currency selling prices of products in response to changes in exchange rates is limited and may not offset the impact of the changes in exchange rates on the translated value of sales or costs. In addition, if we increase the selling price of our products in local currencies, this could have a negative impact on the demand for our products.

*Major customers.* While we have historically depended on a few customers for a large percentage of our annual net sales, the composition of this group can change from year to year. Net sales derived from our five largest customers as a percentage of our net sales was 28% for the nine months ended September 30, 2018 and 28%, 22% and 25% for the full years 2017, 2016 and 2015, respectively. One of our customers accounted for 13% and 14% of our net sales for the nine months ended September 30, 2018 and 2017. We seek to add new customers and to expand our relationships with existing customers. We anticipate that the composition of our significant customers will continue to change. If any of our significant customers substantially reduced their purchases from us, our results would be adversely affected.

### Results of Operations for the three months ended September 30, 2018 compared to the three months ended September 30, 2017

*Net sales.* Net sales decreased by $36.3 million, or 9.2%, to $356.3 million for the three months ended September 30, 2018 from $392.6 million for the three months ended September 30, 2017.

| Sales by Application | Three Months Ended September 30, 2018 | % of Total | 2017 | % of Total | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Materials processing | $334,497 | 93.9% | $374,725 | 95.4% | $(40,228) | (10.7)% |
| Other applications | 21,849 | 6.1% | 17,890 | 4.6% | 3,959 | 22.1% |
| Total | $356,346 | 100.0% | $392,615 | 100.0% | $(36,269) | (9.2)% |

| Sales by Product | Three Months Ended September 30, 2018 | % of Total | 2017 | % of Total | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| High Power Continuous Wave ("CW") Lasers | $227,462 | 63.8% | $244,239 | 62.2% | $(16,777) | (6.9)% |
| Medium Power CW Lasers | 15,825 | 4.4% | 30,423 | 7.7% | (14,598) | (48.0)% |
| Low Power CW Lasers | 3,276 | 0.9% | 3,138 | 0.8% | 138 | 4.4% |
| Pulsed Lasers | 35,408 | 9.9% | 39,881 | 10.2% | (4,473) | (11.2)% |
| Quasi-Continuous Wave ("QCW") Lasers | 18,276 | 5.1% | 23,765 | 6.1% | (5,489) | (23.1)% |
| Other Revenue including Amplifiers, Laser Systems, Service, Parts, Accessories and Change in Deferred Revenue | 56,099 | 15.9% | 51,169 | 13.0% | 4,930 | 9.6% |
| Total | $356,346 | 100.0% | $392,615 | 100.0% | $(36,269) | (9.2)% |

### Materials processing

Sales for materials processing applications decreased due to lower sales from high power lasers, medium power lasers, pulsed lasers and QCW lasers offset by increased revenue from laser systems.

- The decline in high power lasers related to the decrease in sales of metal welding, cutting, and laser sintering applications. The decrease in sales of high power lasers used in metal welding applications was driven by reduced sales into traditional automotive and electric vehicle battery welding, as well as a decrease in average selling prices. Within cutting applications, decreased sales of products at one to five kilowatts, driven by weaker demand in China and Europe and lower average selling prices, were partially offset by increased sales of ultra-high power lasers at six kilowatts or greater.
- The decrease in medium power sales related to weakness in the laser sintering business. In addition, reduced revenue in fine cutting applications was partially attributable to a move to kilowatt scale high power lasers for these applications.
- The decrease in pulsed laser sales were due to the decline in sales of low and high power pulsed products, which were partially offset by the growth in green, ultraviolet and ultrafast pulsed lasers.
- QCW laser sales decreased due to the expected reduction in demand related to the consumer electronics investment cycle, partially offset by growth in higher power QCW products for welding and aerospace drilling applications.
- The decrease in materials processing sales were partially offset by the increase in sales of laser systems and parts and service sales, which are included in Other Revenue in the Sales by Product table above. The increase in laser systems sales was driven by macro-systems and contributions from micro-systems and the seam stepper, which is mainly used for automotive applications.

### Other Applications

Sales from other applications increased with strong growth in communications and government, partially offset by a decline in medical and scientific applications. Government sales increased largely from directed energy applications.

*Cost of sales and gross margin.* Cost of sales decreased by $6.9 million, or 4.1%, to $161.2 million for the three months ended September 30, 2018 from $168.1 million for the three months ended September 30, 2017. Our gross margin decreased to 54.8% for the three months ended September 30, 2018 from 57.2% for the three months ended September 30, 2017. Gross margin decreased due to lower absorption of manufacturing expenses and lower average prices, partially offset by continued cost reduction initiatives that reduced the cost of certain components.

*Sales and marketing expense.* Sales and marketing expense remained consistent at $13.5 million for the three months ended September 30, 2018 compared with $13.4 million for the three months ended September 30, 2017. As a percentage of sales, sales and marketing expense increased to 3.8% of sales for the three months ended September 30, 2018 from 3.4% for the three months ended September 30, 2017 .

*Research and development expense.* Research and development expense increased by $5.4 million, or 21.0%, to $30.9 million for the three months ended September 30, 2018, compared to $25.5 million for the three months ended September 30, 2017. This change was primarily a result of increases in personnel, contractors and consultants, R&D materials and depreciation expense. Research and development continues to focus on developing new products, enhancing performance of existing components, improving production processes, developing manufacturing of new components and refining production processes to improve manufacturing yields and productivity. New products include lasers that operate at different wavelengths such as UV, visible and mid-IR and lasers with ultrafast pulses. We also continue to develop laser based systems for material processing, projection, display and medical as well as accessories such as welding heads, cutting heads and weld monitoring systems. We are developing new transceiver module products for telecommunication applications. In addition to new products, research and development is focused on enhancing the performance of our existing products and components such as diodes and crystals in order to improve the performance of our lasers and reduce their manufacturing cost. As a percentage of sales, research and development expense increased to 8.7% for the three months ended September 30, 2018 from 6.5% for the three months ended September 30, 2017.

*General and administrative expense.* General and administrative expense increased by $3.7 million, or 17.5%, to $25.2 million for the three months ended September 30, 2018 from $21.5 million for the three months ended September 30, 2017. This change was primarily a result of increases in outside services, bad debt and depreciation expense. As a percentage of sales, general and administrative expense increased to 7.1% for the three months ended September 30, 2018 from 5.5% for the three months ended September 30, 2017.

*Effect of exchange rates on net sales, gross profit and operating expenses.* We estimate that, if exchange rates relative to the U.S. Dollar had been the same as one year ago, which were on average Euro 0.85, Russian Ruble 59, Japanese Yen 111 and Chinese Yuan 6.67, respectively, we would have expected net sales to be $8.4 million higher, gross profit to be $4.2 million higher and total operating expenses to be $1.6 million higher.

*(Gain) loss on foreign exchange.* We incurred a foreign exchange loss of $1.7 million for the three months ended September 30, 2018 as compared to a $3.9 million loss for the three months ended September 30, 2017. The foreign exchange loss for the three months ended September 30, 2018 was primarily attributable to depreciation of the Chinese Yuan offset by a gain attributable to depreciation of the Russian Ruble. The foreign exchange loss for the three months ended September 30, 2017 was primarily attributable to the appreciation of the Euro and the Russian Ruble, partially offset by a gain attributable to appreciation of the Chinese Yuan as compared to the U.S. Dollar.

*Provision for income taxes.* Provision for income taxes was $27.4 million for the three months ended September 30, 2018 compared to $45.0 million for the three months ended September 30, 2017. The effective tax rates were 21.4% and 28.0% for the three months ended September 30, 2018 and 2017, respectively. For the three months ended September 30, 2018, the effective tax rate benefited from the lower effective tax rate for income earned in the United States due to enactment of the Tax Cuts and Jobs Act (the "Tax Act"), an increase in excess tax benefits related to equity compensation, provision to return benefits, and a reduction in the estimated full year tax rate due to recent draft proposals issued by the US Treasury Department regarding implementation of the Tax Act. These benefits were partially offset by provisions for uncertain tax positions, a valuation allowance on state tax credits and other matters.

*Net income attributable to IPG Photonics Corporation.* Net income attributable to IPG Photonics Corporation decreased by $15.1 million to $100.5 million for the three months ended September 30, 2018 compared to $115.6 million for the three months ended September 30, 2017. Net income attributable to IPG Photonics Corporation as a percentage of our net sales decreased by 1.2 percentage points to 28.2% for the three months ended September 30, 2018 from 29.4% for the three months ended September 30, 2017 due to the factors described above.

### Results of Operations for the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017

*Net sales.* Net sales increased by $82.0 million, or 7.8%, to $1,129.8 million for the nine months ended September 30, 2018 from $1,047.8 million for the nine months ended September 30, 2017.

| Sales by Application | Nine Months Ended September 30, 2018 | % of Total | 2017 | % of Total | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Materials processing | $1,065,712 | 94.3% | $991,921 | 94.7% | $73,791 | 7.4% |
| Other applications | 64,111 | 5.7% | 55,913 | 5.3% | 8,198 | 14.7% |
| Total | $1,129,823 | 100.0% | $1,047,834 | 100.0% | $81,989 | 7.8% |

| Sales by Product | Nine Months Ended September 30, 2018 | % of Total | 2017 | % of Total | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| High Power CW Lasers | $724,111 | 64.1% | $634,387 | 60.6% | $89,724 | 14.1% |
| Medium Power CW Lasers | 65,092 | 5.8% | 80,152 | 7.7% | (15,060) | (18.8)% |
| Low Power CW Lasers | 10,380 | 0.9% | 9,818 | 0.9% | 562 | 5.7% |
| Pulsed Lasers | 115,243 | 10.2% | 113,442 | 10.8% | 1,801 | 1.6% |
| QCW Lasers | 54,568 | 4.8% | 74,615 | 7.1% | (20,047) | (26.9)% |
| Other Revenue including Amplifiers, Laser Systems, Service, Parts, Accessories and Change in Deferred Revenue | 160,429 | 14.2% | 135,420 | 12.9% | 25,009 | 18.5% |
| Total | $1,129,823 | 100.0% | $1,047,834 | 100.0% | $81,989 | 7.8% |

### Materials processing

Sales for materials processing applications increased due to higher sales of high power lasers, pulsed lasers, and laser systems.

- The growth in high power laser sales related to strength in sales of cutting applications. Within the cutting applications, we continue to see a migration to lasers with higher output powers which improve processing speeds and enable processing of thicker materials. The shift towards lasers with higher output powers has also benefited sales due to their higher average selling prices. The increase in high-power sales was partially offset by a decrease in high-power metal welding sales used in traditional automotive and electric vehicle battery welding
- The decrease in medium power laser sales is due to the shift in cutting to kilowatt-scale lasers and the decrease in sales for laser sintering applications.
- Pulsed laser sales increased due to solar cell manufacturing, and cleaning and stripping, which was partially offset by decreases in welding, and marking & engraving applications. Within the pulsed laser category, the sales for green pulsed lasers increased significantly and sales for low pulsed laser increased slightly, which was partially offset by the decrease in sales of high power pulsed lasers.
- QCW laser sales decreased due to the expected reduction in demand related to the consumer electronics investment cycle.
- Materials processing sales also increased as a result of higher laser systems, accessories including beam delivery, and parts and service sales, which are included in Other Revenue in the Sales by Product chart above. The increase in laser systems sales was driven by welding, cutting, cladding, and other micro-material applications as well as from the acquisition of ILT during the third quarter of 2017.

### Other Applications

Sales from other applications increased with strong growth in government sales and slight growth in communications, instruments, and semiconductor sales which were partially offset by a decline in scientific sales. Within advanced applications, government sales increased primarily due to an increase in sales for directed energy applications.

*Cost of sales and gross margin.* Cost of sales increased by $36.6 million, or 8.0%, to $496.3 million for the nine months ended September 30, 2018 from $459.7 million for the nine months ended September 30, 2017. Our gross margin remained consistent at 56.1% for the nine months ended September 30, 2018 and 2017. Reductions in the cost to manufacture components and lasers were offset by decreases in average selling prices.

*Sales and marketing expense.* Sales and marketing expense increased by $5.2 million, or 14.3%, to $41.5 million for the nine months ended September 30, 2018 from $36.3 million for the nine months ended September 30, 2017, primarily as a result of increased expenses for personnel, trade show and exhibitions, travel and depreciation. As a percentage of sales, sales and marketing expense increased to 3.7% of sales for the nine months ended September 30, 2018 from 3.5% for the nine months ended September 30, 2017.

*Research and development expense.* Research and development expense increased by $17.0 million, or 22.9%, to $91.3 million for the nine months ended September 30, 2018, compared to $74.3 million for the nine months ended September 30, 2017, primarily as a result of an increase in expenses related to personnel, contractors, consultants, materials used for research and development projects, premise-related costs and depreciation. Research and development continues to focus on developing new products, enhancing performance of existing components, improving production processes, developing manufacturing of new components and refining production processes to improve manufacturing yields and productivity. New products include lasers that operate at different wavelengths such as UV, visible and mid-IR and lasers with ultrafast pulses. We also continue to develop laser based systems for material processing, projection, display and medical as well as accessories such as welding heads, cutting heads and weld monitoring systems. We are developing new transceiver module products for telecommunication applications. In addition to new products, research and development is focused on enhancing the performance of our existing products and components such as diodes and crystals in order to improve the performance of our lasers and reduce their manufacturing cost. As a percentage of sales, research and development expense increased to 8.1% for the nine months ended September 30, 2018 from 7.1% for the nine months ended September 30, 2017.

*General and administrative expense.* General and administrative expense increased by $15.8 million, or 26.7%, to $74.9 million for the nine months ended September 30, 2018 from $59.1 million for the nine months ended September 30, 2017, primarily as a result of increased expenses for personnel, legal, accounting, information technology, and depreciation. As a percentage of sales, general and administrative expense increased to 6.6% for the nine months ended September 30, 2018 from 5.6% for the nine months ended September 30, 2017.

*Effect of exchange rates on net sales, gross profit and operating expenses.* We estimate that, if exchange rates relative to the U.S. Dollar had been the same as one year ago, which were on average Euro 0.90, Russian Ruble 58, Japanese Yen 112 and Chinese Yuan 6.81, respectively, we would have expected net sales for the nine months ended September 30, 2018 to be $43.9 million lower, gross profit to be $29.1 million lower and total operating expenses would have been $0.5 million lower.

*(Gain) Loss on foreign exchange.* We incurred a foreign exchange gain of $1.5 million for the nine months ended September 30, 2018 as compared to a loss of $15.6 million for the nine months ended September 30, 2017. The gain for the nine months ended September 30, 2018 was primarily attributable to the depreciation of the Euro and the Russian Ruble as compared to the U.S. Dollar, which was partially offset by a loss attributable to depreciation of the Chinese Yuan. The loss for the nine months ended September 30, 2017 was primarily attributable to appreciation of the Euro and Russian Ruble compared to the U.S. Dollar, which was partially offset by a gain from appreciation of the Chinese Yuan.

*Provision for income taxes.* Provision for income taxes was $104.8 million for the nine months ended September 30, 2018 compared to $108.8 million for the nine months ended September 30, 2017, representing an effective tax rate of 24.2% and 27.0% for the nine months ended September 30, 2018 and 2017, respectively. The effective tax rate benefited from the lower effective tax rate for income earned in the United States due to enactment of the Tax Cuts and Jobs Act (the "Tax Act"), an increase in excess tax benefits related to equity compensation and provision to return benefits, which were partially offset by provisions for uncertain tax positions, a valuation allowance on state tax credits and other matters.

*Net income attributable to IPG Photonics Corporation.* Net income attributable to IPG Photonics Corporation increased by $33.8 million to $328.5 million for the nine months ended September 30, 2018 compared to $294.7 million for the nine months ended September 30, 2017. Net income attributable to IPG Photonics Corporation as a percentage of our net sales increased by 1.0 percentage point to 29.1% for the nine months ended September 30, 2018 from 28.1% for the nine months ended September 30, 2017 due to the factors described above.

### Liquidity and Capital Resources

Our principal sources of liquidity as of September 30, 2018 consisted of cash and cash equivalents of $647.6 million, short-term investments of $474.4 million, unused credit lines and overdraft facilities of $108.2 million and other working capital (excluding cash and cash equivalents and short-term investments) of $542.3 million. This compares to cash and cash equivalents of $909.9 million, short-term investments of $206.3 million, unused credit lines and overdraft facilities of $111.0 million and other working capital (excluding cash and cash equivalents and short-term investments) of $439.0 million as of December 31, 2017. The decrease in cash and cash equivalents of $262.3 million relates primarily to cash used in investing activities of $416.9 million and cash used in financing activities of $102.1 million. The cash used in investing activities includes $280.2 million of net investment purchases and $132.6 million of net property, plant and equipment purchases. The increase in net investment purchases is due to an increase in cash held in the United States as a result of the payment of an intercompany dividend from our German subsidiary to the U.S. parent. The dividend was declared in the second quarter of 2018 in order to repatriate cash so that it can be managed centrally and invested in higher yielding U.S. Dollar denominated investments which is the functional currency of our parent company. The dividend was paid in full by the end of the third quarter 2018. The cash used in financing activities primarily relates to $111.9 million of treasury stock purchases under our anti-dilutive share repurchase program. These outflows were partially offset by cash provided by operating activities in the nine months ended September 30, 2018 of $280.3 million. In addition, the effect of exchange rates decreased cash and cash equivalents by $23.5 million.

Short-term investments at September 30, 2018, consist of liquid investments including U.S. government and government agency notes, corporate notes, commercial paper and certificates of deposit with original maturities of greater than three months but less than one year. We also hold long-term investments, included in other assets on the consolidated balance sheets, which consist of the corporate bonds detailed above with maturities of less than two years and auction rate securities totaling $14,620.

Our long-term debt consists of two long-term notes with a combined total outstanding balance at September 30, 2018 of $46.3 million of which $3.7 million is the current portion. We have an unsecured long-term note with an outstanding principal balance at September 30, 2018 of $21.1 million of which $1.2 million is the current portion. The interest on this unsecured long-term note is variable at 1.20% above LIBOR and is fixed using an interest rate swap at 2.85% per annum. The unsecured long-term note matures in May 2023, at which time the outstanding principal balance will be $15.4 million. We have another long-term note that is secured by our corporate aircraft with an outstanding principal balance of $25.2 million of which $2.5 million is the current portion. The interest on this collateralized long-term note is fixed at 2.74% per annum. The collateralized long-term note matures in July 2022, at which time the outstanding principal balance will be $15.4 million.

We believe that our existing cash and cash equivalents, short-term investments, our cash flows from operations and our existing lines of credit provide us with the financial flexibility to meet our liquidity and capital needs, as well as to complete certain acquisitions of businesses and technologies. We intend to continue to pursue acquisition opportunities based upon market conditions and the strategic importance and valuation of the target company. We may consider issuing debt or equity to finance acquisitions depending on the timing and size of the acquisition. Our future long-term capital requirements will depend on many factors including our level of sales, the impact of the economic environment on our sales growth, the timing and extent of spending to support development efforts, the expansion of the global sales and marketing activities, government regulation including trade sanctions, the timing and introductions of new products, the need to ensure access to adequate manufacturing capacity and the continuing market acceptance of our products.

The following table details our line-of-credit facilities as of September 30, 2018:

| Description | Total Facility | Interest Rate | Maturity | Security |
| --- | --- | --- | --- | --- |
| U.S. Revolving Line of Credit (1) | $50.0 million | LIBOR plus 0.80% to 1.20%, depending on our performance | April 2020 | Unsecured |
| Euro Credit Facility (Germany) (2) | Euro 50.0 million ($58.0 million) | Euribor plus 0.75% or EONIA 1.00% | July 2020 | Unsecured, guaranteed by parent company and German subsidiary |
| Euro Overdraft Facilities (3) | Euro 2.0 million ($2.3 million) | Euribor plus 0.89% to 1.10% | May 2019 | Common pool of assets of Italian subsidiary |

(1) This facility is available to certain foreign subsidiaries in their respective local currencies. At September 30, 2018, there were no amounts drawn on this line, however, there were $1.0 million of guarantees issued against the line which reduces total availability.

(2) This facility is also available to certain foreign subsidiaries in their respective local currencies. At September 30, 2018, there were no drawings on this facility, however, there were $1.2 million of guarantees issued against the line which reduces total availability.

(3) At September 30, 2018, there were no drawings. This facility renews annually.

Our largest committed credit lines are with Bank of America N.A. and Deutsche Bank AG in the amounts of $50.0 million and $58.0 million (or 50 million Euro as described above), respectively, and neither of them is syndicated.

We are required to meet certain financial covenants associated with our U.S. revolving line of credit and long-term debt facility. These covenants, tested quarterly, include a debt service coverage ratio and a funded debt to earnings before interest, taxes, depreciation and amortization ("EBITDA") ratio. The debt service coverage covenant requires that we maintain a trailing twelve month ratio of cash flow to debt service that is at least 1.5:1. Debt service is defined as required principal and interest payments during the period. Debt service in the calculation is decreased by our cash held in the U.S.A. in excess of $50 million up to a maximum of $250 million. Cash flow is defined as EBITDA less unfunded capital expenditures. The funded debt to EBITDA covenant requires that the sum of all indebtedness for borrowed money on a consolidated basis be less than three times our trailing twelve months EBITDA. We were in compliance with all such financial covenants as of and for the three months ended September 30, 2018.

The financial covenants in our loan documents may cause us to not make or to delay investments and actions that we might otherwise undertake because of limits on capital expenditures and amounts that we can borrow or lease. In the event that we do not comply with any one of these covenants, we would be in default under the loan agreement or loan agreements, which may result in acceleration of the debt, cross-defaults on other debt or a reduction in available liquidity, any of which could harm our results of operations and financial condition.

*Operating activities.* Net cash provided by operating activities decreased by $16.6 million to $280.3 million for the nine months ended September 30, 2018 from $296.9 million for the nine months ended September 30, 2017. Our largest working capital items are inventory and accounts receivable. Items such as accounts payable to third parties, prepaid expenses and other current assets and accrued expenses and other liabilities are not as significant as our working capital investment in accounts receivable and inventory because of the amount of value added within IPG due to our vertically integrated structure. Accruals and payables for personnel costs including bonuses and income and other taxes payable are largely dependent on the timing of payments for those items. The decreased cash flow from operating activities for the nine months ended September 30, 2018 primarily resulted from:

- An increase of $22.7 million in cash provided by net income after adding back non-cash charges to $438.9 million for the nine months ended September 30, 2018 as compared to $416.2 million for the same period in 2017;
- A decrease in the cash used for accounts receivable of $26.1 million for the nine months ended September 30, 2018 as compared to $56.4 million for the same period in 2017; and
- An increase in cash provided by income taxes. Cash provided by income and other taxes payable was $15.8 million for the nine months ended September 30, 2018 as compared to cash used for income and other taxes payable of $26.9 million for the same period in 2017; partially offset by
- An increase in the cash used for inventory. Cash used for inventory was $122.1 million for the nine months ended September 30, 2018 as compared to $39.7 million for the same period in 2017.

Given our vertical integration, rigorous and time-consuming testing procedures for both internally manufactured and externally purchased components and the lead time required to manufacture components used in our finished products, the rate at which we turn inventory has historically been comparatively low when compared to our cost of sales. Also, our historic growth rates required investment in inventories to support future sales and enable us to quote short delivery times to our customers, providing what we believe is a competitive advantage. Furthermore, if there was a disruption to the manufacturing capacity of any of our key technologies, our inventories of components should enable us to continue to build finished products for a period of time. We believe that we will continue to maintain a relatively high level of inventory compared to our cost of sales. As a result, we expect to have a significant amount of working capital invested in inventory. A reduction in our level of net sales or the rate of growth of our net sales from their current levels would mean that the rate at which we are able to convert our inventory into cash would decrease.

*Investing activities.* Net cash used in investing activities was $416.9 million for the nine months ended September 30, 2018 as compared to cash used in investing activities of $93.3 million in 2017. The cash used in investing activities in 2018 related to $133.4 million of capital expenditures and $280.2 million of net purchases of short-term and long-term investments.

The cash used in investing activities in 2017 related to $99.2 million of capital expenditures, partially offset by $41.6 million of net proceeds from sales and maturities of short-term investments.

We expect to incur between $170 million and $190 million in 2018 in capital expenditures. Capital expenditures include investments in facilities and equipment to add capacity worldwide to support anticipated revenue growth. In 2018, we expect capital expenditures to increase as a percentage of revenue to support the growth of our business. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. If we obtain financing for certain projects, our cash expenditures would be reduced in the year of expenditure. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer to a later period.

*Financing activities.* Net cash used in financing activities was $102.1 million for the nine months ended September 30, 2018 as compared to net cash provided of $5.2 million in 2017. The cash used in financing activities in 2018 was primarily related the purchase of treasury stock of $111.9 million, partially offset by proceeds of $12.1 million from the exercise of stock options and shares issued under our employee stock purchase plan. The cash provided by financing activities in 2017 was primarily related to the proceeds of $23.3 million from the exercise of stock options and shares issued under our employee stock purchase plan and net proceeds from long-term borrowings of $9.0 million, partially offset by the purchase of treasury stock of $26.9 million.

### Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Quarterly Report on Form 10-Q except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements.

The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 1, "Business" and Item 1A, "Risk Factors" of Part I of our Annual Report on Form 10-K for the year ended December 31, 2017. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to rely on such forward-looking information. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

### Recent Accounting Pronouncements

See Note 2 in the Notes to Consolidated Financial Statements for a full description of recent accounting pronouncements, including the respective dates of adoption or expected adoption and effects on our consolidated financial statements contained in Item 1 of this Quarterly Report.

## Market risk

As filed, 5,357 characters.

We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and our debt and foreign exchange rate risk.

*Interest rate risk*. Certain interest rates are variable and fluctuate with current market conditions. Our investments have limited exposure to market risk. We maintain a portfolio of cash, cash equivalents and short-term investments, consisting primarily of bank deposits, money market funds, certificates of deposit, corporate bonds and government and agency securities. None of these investments have a maturity date in excess of one year. Because of the short-term nature of these instruments, a sudden change in market interest rates would not be expected to have a material impact on our financial condition or results of operations. We also have long-term investments in corporate notes with maturities between one and two years. Given the modest amount of our long-term investments totaling $14.6 million and the fact that we expect to hold these investments to maturity, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

We are also exposed to market risk as a result of increases or decreases in the amount of interest expense we must pay on our bank debt and borrowings on our bank credit facilities. Our interest obligations on our long-term debt are fixed either by the underlying agreement or by means of an interest rate swap agreement. Although our U.S. revolving line of credit and our Euro credit facility have variable rates, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

*Exchange rates.* Due to our international operations, a significant portion of our net sales, cost of sales and operating expenses are denominated in currencies other than the U.S. Dollar, principally the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. As a result, our international operations give rise to transactional market risk associated with exchange rate movements of the U.S. Dollar, the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. The loss on foreign exchange transactions totaled $1.7 million for the three months ended September 30, 2018 compared to the loss of $3.9 million for the three months ended September 30, 2017. Management attempts to minimize these exposures by partially or fully off-setting foreign currency denominated assets and liabilities at our subsidiaries that operate in different functional currencies. The effectiveness of this strategy can be limited by the volume of underlying transactions at various subsidiaries and by our ability to accelerate or delay inter-company cash settlements. As a result, we are unable to create a perfect offset of the foreign currency denominated assets and liabilities. At September 30, 2018, our material foreign currency exposure is net U.S. Dollar denominated assets at subsidiaries where the Euro or the Russian Ruble is the functional currency and U.S. Dollar denominated liabilities where the Chinese Yuan is the functional currency. The U.S. Dollar denominated assets are comprised of cash, third party receivables and inter-company receivables. The U.S. Dollar denominated liabilities are comprised of inter-company payables. A 5% change in the relative exchange rate of the U.S. Dollar to the Euro as of September 30, 2018 applied to the net U.S. Dollar asset balances, would result in a foreign exchange gain of $4.5 million if the U.S. Dollar appreciated and a $4.5 million foreign exchange loss if the U.S. Dollar depreciated. A 5% change in the relative exchange rate of the U.S. Dollar to the Chinese Yuan as of September 30, 2018 applied to the net U.S. Dollar liabilities balances, would result in a foreign exchange loss of $5.6 million if the U.S. Dollar appreciated and a $5.6 million foreign exchange gain if the U.S. Dollar depreciated.

In addition we are exposed to foreign currency translation risk for those subsidiaries whose functional currency is not the U.S. Dollar as changes in the value of their functional currency relative to the U.S. Dollar can adversely affect the translated amounts of our revenue, expenses, net income, assets and liabilities. This can, in turn, affect the reported value and relative growth of sales and net income from one period to the next. In addition changes in the translated value of assets and liabilities due to changes in functional currency exchange rates relative to the U.S. Dollar result in foreign currency translation adjustments that are a component of other comprehensive income or loss.

Foreign currency derivative instruments can also be used to hedge exposures and reduce the risks of certain foreign currency transactions; however, these instruments provide only limited protection and can carry significant cost. We have no foreign currency derivative instruments as of September 30, 2018. We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. Exchange rate fluctuations may adversely affect our financial results in the future.

## Controls and procedures

As filed, 1,030 characters.

### Evaluation of Disclosure Controls and Procedures

Under the supervision of our chief executive officer and our chief financial officer, our management has evaluated the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"). Based upon that evaluation, our chief executive officer and our chief financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.

### Changes in Internal Controls

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 637 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2017, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Filed Nov 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001111928-18-000137. Last ingested by Listed: Nov 4, 2026, 17:26 ET. No prices; not investment advice.
